Drugs / PA-001
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07086677 | Jul 2025 → Oct 2027 expected | pneumococcal infection | Pfizer | Active not recruiting | No outcome recorded |
| Phase 1 | NCT07518771 | Jul 2024 → Jun 2025 | COVID-19 | PeptiDream Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PA-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07086677 ↗ |
| Route | Intravenous | “infused via IV” NCT07518771 ↗ |